JP2000505793A - 2,3―ベンゾジアゼピン誘導体及びそのampa―レセプター抑制剤としての使用 - Google Patents
2,3―ベンゾジアゼピン誘導体及びそのampa―レセプター抑制剤としての使用Info
- Publication number
- JP2000505793A JP2000505793A JP9527247A JP52724797A JP2000505793A JP 2000505793 A JP2000505793 A JP 2000505793A JP 9527247 A JP9527247 A JP 9527247A JP 52724797 A JP52724797 A JP 52724797A JP 2000505793 A JP2000505793 A JP 2000505793A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- alkyl
- methoxy
- benzodiazepine
- aminophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 式I [式中、 Xは水素又はハロゲンを表わし、 Yは−NR3−又は−N=を表わし、 R1及びR2は同一又は異なるものを表わし、水素、C1-6−アルキル、ニトロ、 ハロゲン、基−NR8R9、−O−C1-4−アルキル、−CF3、OH又はCl-6− アルカノイルオキシを表わし、 R3は水素、基−CO−R10、及びC1-6−アルキル又はC3-7−シクロアルキル を表わし、 R4は置換又は非置換C1-6−アルキルを表わし、 R5は水素を表わし、又は R4及びR5は一緒になって酸素を表わし、 R6はC1-4−アルキルを表わし、 R8及びR9は同一又は異なるものを表わし、水素、C1-6−アルキル又は基−C O−C1-6−アルキルを 表わし、 R10は水素、非置換又は置換C1-6−アルキル、非置換又は置換C6-10−アリー ル、基−NR11R12、−O−C1-6−アルキル、C3-7−シクロアルキル、C2-6 −アルケニル又は−O−C3-7−シクロアルキルを表わし、かつ R11及びR12は同一又は異なっており、水素、非置換又は置換C1-6−アルキル 又は置換又は非置換C6-10−アリールを表わし、かつ 及びその異性体及び生理学的に認容性の塩。 2. 請求項1記載の、 1−(4−アミノフェニル)−8−メトキシ−4,5−ジヒドロ−3H−2, 3−ベンゾジアゼピン−4−オン 1−(4−アミノフェニル)−4−メチル−8−メトキシ−5H−2,3−ベ ンゾジアゼピン 3−アセチル−1−(4−アミノフェニル)−4−メチル−8−メトキシ−4 ,5−ジヒドロ−3H−2,3−ベンゾジアゼピン 3−n−プロピオニル−1−(4−アミノフェニル)−4−メチル−8−メト キシ−4,5−ジヒドロ−3H−2,3−ベンゾジアゼピン 3−シクロプロピルカルボニル−1−(4−アミノフェニル)−4−メチル− 8−メトキシ−4,5− ジヒドロ−3H−2,3−ベンゾジアゼピン 3−メトキシカルボニル−1−(4−アミノフェニル)−4−メチル−8−メ トキシ−4,5−ジヒドロ−3H−2,3−ベンゾジアゼピン 3−メチルカルバモイル−1−(4−アミノフェニル)−4−メチル−8−メ トキシ−4,5−ジヒドロ−3H−2,3−ベンゾジアゼピン 3−アセチル−1−(4−アミノフェニル)−4−メチル−8−メトキシ−3 H−2,3−ベンゾジアゼピン 3−n−プロピオニル−1−(4−アミノフェニル)−4−メチル−8−メト キシ−3H−2,3−ベンゾジアゼピン 3−シクロプロピルカルボニル−1−(4−アミノフェニル)−4−メチル− 8−メトキシ−3H−2,3−ベンゾジアゼピン。 3. 請求項1記載の式Iの化合物を含有する薬剤。 4. a)一般式II [式中、R1、R2、R6及びXは前記のものを表わし、Rはヒドロキシ又はC1-6 −アルキルである] の化合物をH2N−NH−R3で環化するか、又は b)一般式III [式中、R1、R2、R4、R6及びXは前記のものを表わし、A-は有機塩基のア ニオンを表わす]の化合物をH2N−NHR3と反応させ、かつ所望の場合は引き 続きニトロ基及び/又は3,4−二重結合を還元しかつ/又は一般式Iの化合物 を還元、脱ハロゲン化、アシル化、アルキル化、ヒドロキシル化、ハロゲン化、 カルバモイル基又はエステル基の導入により、他の一般式Iの化合物に変換し、 異性体を分離し、又は塩を形成する、 ことにより請求項1記載の式Iの化合物を製造する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19604920A DE19604920A1 (de) | 1996-02-01 | 1996-02-01 | Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel |
DE19604920.2 | 1996-02-01 | ||
PCT/DE1997/000225 WO1997028135A1 (de) | 1996-02-01 | 1997-01-29 | 2,3-benzodiazepinderivate und deren verwendung als ampa-rezeptoren-hemmer |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000505793A true JP2000505793A (ja) | 2000-05-16 |
Family
ID=7785065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9527247A Ceased JP2000505793A (ja) | 1996-02-01 | 1997-01-29 | 2,3―ベンゾジアゼピン誘導体及びそのampa―レセプター抑制剤としての使用 |
Country Status (14)
Country | Link |
---|---|
US (1) | US6200970B1 (ja) |
EP (1) | EP0888313B1 (ja) |
JP (1) | JP2000505793A (ja) |
AT (1) | ATE216373T1 (ja) |
AU (1) | AU2285997A (ja) |
CA (1) | CA2244777C (ja) |
DE (2) | DE19604920A1 (ja) |
DK (1) | DK0888313T3 (ja) |
ES (1) | ES2175386T3 (ja) |
HU (1) | HUP9901473A3 (ja) |
MX (1) | MX9806171A (ja) |
PT (1) | PT888313E (ja) |
WO (1) | WO1997028135A1 (ja) |
ZA (1) | ZA97850B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006502174A (ja) * | 2002-09-13 | 2006-01-19 | モタック・ニューロサイエンス・リミテッド | 2,3−ベンゾジアゼピンによる基底核関連運動障害の治療 |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891871A (en) * | 1996-03-21 | 1999-04-06 | Cocensys, Inc. | Substituted 2,3-benzodiazepin-4-ones and the use thereof |
BRPI0111596B8 (pt) | 2000-06-12 | 2022-07-26 | Eisai Co Ltd | Composto piridona, processo de produção do composto, composição farmacêutica, e uso do dito composto |
WO2001098280A2 (en) * | 2000-06-16 | 2001-12-27 | Annovis, Inc. | 5h-2,3-benzodiazepine antagonists of excitatory amino acid receptors |
US6432944B1 (en) | 2000-07-06 | 2002-08-13 | Bristol-Myers Squibb Company | Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives |
HU225100B1 (hu) * | 2000-12-21 | 2006-06-28 | Egyt Gyogyszervegyeszeti Gyar | 2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk |
AU2002317910B2 (en) * | 2001-06-07 | 2008-06-19 | Via Pharmaceuticals, Inc. | Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
GB0129260D0 (en) | 2001-12-06 | 2002-01-23 | Eisai London Res Lab Ltd | Pharmaceutical compositions and their uses |
EP1539135B1 (en) * | 2002-09-17 | 2007-04-25 | Motac Neuroscience Limited | Treatment of dyskinesia |
US20040141152A1 (en) * | 2002-09-27 | 2004-07-22 | Marino Joseph A. | Apparatus and method for conducting vision screening |
US6858605B2 (en) * | 2003-02-04 | 2005-02-22 | Ivax Drug Research Institute, Ltd. | Substituted 2,3-benzodiazepine derivatives |
HUP0302449A3 (en) * | 2003-08-04 | 2005-06-28 | Egis Gyogyszergyar Nyilvanosan | 8-chloro-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for producing them |
MY148809A (en) | 2004-07-06 | 2013-05-31 | Eisai R&D Man Co Ltd | Crystals of 1,2-dihydropyridine compound and their production process |
AU2006334172A1 (en) * | 2005-12-30 | 2007-07-12 | Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag | Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis |
TW200902024A (en) * | 2007-04-02 | 2009-01-16 | Teva Pharma | Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents |
PE20150729A1 (es) * | 2012-08-16 | 2015-06-14 | Bayer Pharma AG | 2,3-benzodiazepines |
KR20150119926A (ko) | 2013-02-19 | 2015-10-26 | 바이엘 파마 악티엔게젤샤프트 | 비시클로 2,3-벤조디아제핀 및 스피로시클릭 치환된 2,3-벤조디아제핀 |
WO2015121268A1 (de) * | 2014-02-14 | 2015-08-20 | Bayer Pharma Aktiengesellschaft | 1-phenyl-3h-2,3-benzodiazepine und ihre verwendung als bromodomänen-inhibitoren |
JP7177937B2 (ja) | 2018-12-14 | 2022-11-24 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 1,2-ジヒドロピリジン化合物の水性医薬製剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU179018B (en) | 1978-10-19 | 1982-08-28 | Gyogyszerkutato Intezet | Process for producing new 5h-2,3-benzodiazepine derivatives |
HU186760B (en) * | 1981-03-12 | 1985-09-30 | Gyogyszerkutato Intezet | Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives |
HU191698B (en) | 1984-07-27 | 1987-03-30 | Gyogyszerkutato Intezet | Process for producing new 1-aryl-5h-2beta-benzodiazepines |
HU208429B (en) | 1991-05-03 | 1993-10-28 | Gyogyszerkutato Intezet | Process for producing 1-/3-chloro-phenyl/-4-methyl-7,8-dimethoxy-5h-2,3-benzodiazepine of high purity |
US5891871A (en) * | 1996-03-21 | 1999-04-06 | Cocensys, Inc. | Substituted 2,3-benzodiazepin-4-ones and the use thereof |
-
1996
- 1996-02-01 DE DE19604920A patent/DE19604920A1/de not_active Withdrawn
-
1997
- 1997-01-29 AU AU22859/97A patent/AU2285997A/en not_active Abandoned
- 1997-01-29 DK DK97915277T patent/DK0888313T3/da active
- 1997-01-29 PT PT97915277T patent/PT888313E/pt unknown
- 1997-01-29 AT AT97915277T patent/ATE216373T1/de not_active IP Right Cessation
- 1997-01-29 HU HU9901473A patent/HUP9901473A3/hu unknown
- 1997-01-29 WO PCT/DE1997/000225 patent/WO1997028135A1/de active IP Right Grant
- 1997-01-29 EP EP97915277A patent/EP0888313B1/de not_active Expired - Lifetime
- 1997-01-29 DE DE59707062T patent/DE59707062D1/de not_active Expired - Fee Related
- 1997-01-29 ES ES97915277T patent/ES2175386T3/es not_active Expired - Lifetime
- 1997-01-29 US US09/125,008 patent/US6200970B1/en not_active Expired - Fee Related
- 1997-01-29 CA CA002244777A patent/CA2244777C/en not_active Expired - Fee Related
- 1997-01-29 JP JP9527247A patent/JP2000505793A/ja not_active Ceased
- 1997-01-31 ZA ZA9700850A patent/ZA97850B/xx unknown
-
1998
- 1998-07-31 MX MX9806171A patent/MX9806171A/es not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006502174A (ja) * | 2002-09-13 | 2006-01-19 | モタック・ニューロサイエンス・リミテッド | 2,3−ベンゾジアゼピンによる基底核関連運動障害の治療 |
Also Published As
Publication number | Publication date |
---|---|
ES2175386T3 (es) | 2002-11-16 |
EP0888313A1 (de) | 1999-01-07 |
AU2285997A (en) | 1997-08-22 |
HUP9901473A3 (en) | 2001-07-30 |
ATE216373T1 (de) | 2002-05-15 |
DE59707062D1 (de) | 2002-05-23 |
ZA97850B (en) | 1997-08-04 |
MX9806171A (es) | 1998-10-31 |
EP0888313B1 (de) | 2002-04-17 |
DK0888313T3 (da) | 2002-07-15 |
US6200970B1 (en) | 2001-03-13 |
HUP9901473A2 (hu) | 1999-09-28 |
CA2244777C (en) | 2006-11-07 |
DE19604920A1 (de) | 1997-08-07 |
CA2244777A1 (en) | 1997-08-07 |
WO1997028135A1 (de) | 1997-08-07 |
PT888313E (pt) | 2002-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000505793A (ja) | 2,3―ベンゾジアゼピン誘導体及びそのampa―レセプター抑制剤としての使用 | |
JPH0570463A (ja) | N−アシル−2,3−ベンゾジアゼピン誘導体、その製造法、それを含有する製剤組成物、およびその製造法 | |
US5461061A (en) | Centrally acting 6,7,8,9-tetrahydro-3H-benz(E)indole heterocyclics | |
US4613603A (en) | Compounds with a nitrogen-containing heterocyclic nucleus, and drugs in which they are present | |
JPS60258162A (ja) | 6‐酸素化‐1,3,4,5‐テトラヒドロベンズ[cd]インドール‐4‐アミン | |
JP3131767B2 (ja) | 新規な2,3−ベンゾジアゼピン誘導体 | |
FI113177B (fi) | Uusia 1,3-dioksolo[4,5-h]-, 1,4-dioksano[2,3-h]- ja 1,5-dioksepino[2,3-h] [2,3]bentsodiatsepiinijohdannaisia, niiden valmistus ja käyttö lääkkeenä | |
US4218448A (en) | Antihypertensive polyfluorohydroxyisopropyl bicyclic and tricyclic carbostyrils | |
JPH11158179A (ja) | 新規インダノール化合物、それらの製法及びそれらを含む医薬組成物 | |
JPH07291974A (ja) | エピ−エピバチジン誘導体及びその製造法 | |
EA005071B1 (ru) | ЗАМЕЩЕННЫЕ ПИРАЗОЛО[4,3-e]ДИАЗЕПИНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ, И ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ ПРОДУКТОВ | |
JP2001512124A (ja) | 新規な2,3−ベンゾジアゼピン誘導体 | |
CZ20023674A3 (cs) | Nové polycyklické indanylimidazolové sloučeniny s alfa2 adrenergní aktivitou | |
JP3128750B2 (ja) | 1−[2−(置換ビニル)]−5h−2,3−ベンゾジアゼピン誘導体 | |
US5041460A (en) | Heter-aliphatic carboxamides | |
AU752412B2 (en) | Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors | |
US5057534A (en) | 3-amino-5-arylpyrazole-4-acetic acid derivatives exhibiting therapeutic effects | |
JPS624250A (ja) | ベンズ三置換−2−アミノテトラリン | |
JPS5810387B2 (ja) | 4,5,6,7テトラヒドロイミダゾ〔4,5−c〕ピリジン誘導体及びその製法 | |
JPH09500359A (ja) | ピリド〔1,2,3−de〕キノキサリン誘導体、その製法及び薬剤へのその使用 | |
JPS6043068B2 (ja) | アゼピノ〔1,2,3−1m〕−β−カルボリン誘導体及びその製法 | |
JP3018573B2 (ja) | ベンズアゼピノピリダジン化合物 | |
US5047402A (en) | Cyclic amides as medicaments | |
JPH06298757A (ja) | ピペリジノ−3,4−ジヒドロカルボスチリル誘導体 | |
EP0726257A1 (en) | 1-(Hetero)Arylvinyl-5H-2,3-benzodiazepine derivatives useful for the treatment of central nervous system disorders, and benzopyrylium intermediates for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20031128 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061003 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070104 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070226 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20070516 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070626 |